Headache Medicine
Medication-Overuse Headache
Medication-overuse headache requires recognition of class-specific acute-medication thresholds, exclusion of alternative secondary headache causes, and a planned withdrawal strategy. Most patients stop nonopioid acute agents abruptly while migraine prevention and close follow-up address withdrawal symptoms, persistent migraine, and relapse risk.
Diagnosis
Confirm the medication-use pattern before attributing chronic headache to overuse
A medication diary is the highest-yield first test.
Obtain a prospective 30-day headache and medication diary that records headache days, acute-medication days by class, dose, and use of combination products. Diagnose medication-overuse headache when headache is present on more than 15 days per month, acute headache medication has been overused for more than 3 months, and headache developed or worsened during that exposure pattern. Patients with both chronic migraine and medication-overuse headache should retain both diagnoses because withdrawal does not replace treatment of the underlying migraine disorder. Neurology+1NeurologyEptinezumab With Patient Education for Chronic Migraine and Medication-Overuse HeadacheWHOPHC ENG GUIDE 200 - Extranet Systems
Classify overuse by medication days rather than total pills. The operational threshold is at least 10 days per month for triptans, ergotamine, opioids, and combination analgesics; combination products include agents such as Excedrin, barbiturate-containing products, and Midrin. The threshold is at least 15 days per month for aspirin, acetaminophen, ibuprofen, naproxen sodium, or other prescription NSAIDs used alone. Apply the multiple-class overuse category when aggregate acute-medication exposure meets overuse criteria although no single class does. Neurology+1NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems
Do not diagnose medication-overuse headache solely because the patient has frequent medication exposure. The association between acute-medication use and frequent headache is complicated by confounding from the underlying headache burden; use the diary together with temporal worsening during overuse and response after withdrawal to reassess the diagnosis. NeurologyNeurologyMedication overuse headache
Ask specifically about OTC acetaminophen, aspirin, ibuprofen, naproxen, caffeine-containing combination products, barbiturate-containing products, opioids, triptans, and ergotamine; patients may not identify OTC combination products as headache medication. NeurologyNeurologyMedication Overuse and Headache Burden
Document the antecedent headache phenotype and current headache-day burden before withdrawal so that residual migraine or another primary headache disorder can be treated after detoxification. Nature+1NatureDiagnosis and management of migraine in ten stepsNeurologyEptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache
| Acute medication class | Overuse threshold | Clinical implication |
|---|---|---|
| Triptans, ergotamine, opioids | At least 10 days per month for more than 3 months Neurology+1NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems | Meets class-specific overuse threshold in a patient with headache on more than 15 days monthly. WHOWHOPHC ENG GUIDE 200 - Extranet Systems |
| Combination analgesics, including caffeine- or barbiturate-containing products | At least 10 days per month for more than 3 months Neurology+1NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems | Assign combination-analgesic-overuse headache when diagnostic criteria are met. WileyWileyEuropean Academy of Neurology guideline on the ... |
| Acetaminophen, aspirin, NSAIDs used alone | At least 15 days per month for more than 3 months Neurology+1NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems | Meets simple-analgesic overuse threshold in a patient with headache on more than 15 days monthly. WHOWHOPHC ENG GUIDE 200 - Extranet Systems |
| Multiple acute-medication classes | Aggregate use may meet criteria when no single class reaches its individual threshold. NeurologyNeurologyMedication Overuse and Headache Burden | Identify all contributing agents before constructing the withdrawal plan. NeurologyNeurologyMedication Overuse and Headache Burden |
Initial Assessment
Separate likely medication overuse from urgent secondary headache
Medication overuse should not terminate the secondary-headache assessment.
At the initial visit, compare the current headache with the patient's established phenotype and determine whether the frequency increase tracks acute-medication escalation. A stable migraine-like phenotype with qualifying medication exposure supports medication-overuse headache; a distinctly new phenotype, progressive focal neurologic symptoms, altered consciousness, systemic illness, or abrupt severe onset requires evaluation for an alternative secondary cause before assuming medication overuse.
Prioritize opioid exposure as a separate management branch. Opioids can contribute to medication-overuse headache and opioid-induced hyperalgesia, and abrupt discontinuation is not the default strategy for opioid overuse. Establish the prescribed and nonprescribed opioid regimen, duration of use, prior withdrawal symptoms, and concurrent sedative exposure, then select a tapering plan rather than an unsupervised abrupt stop. cell+2cellPACAP-PAC1 receptor inhibition is effective in opioid ...NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems
Refer chronic migraine with medication overuse to headache-specialist care when withdrawal fails, diagnostic uncertainty persists, opioid or other addictive-drug use complicates management, or preventive treatment selection requires escalation. Chronic migraine itself is a specialist-referral indication in the ten-step migraine management framework. NatureNatureDiagnosis and management of migraine in ten steps
Use the diary to identify whether morning or persistent daily headache coincides with medication escalation; medication-overuse headache is often persistent and may be worst on awakening. WHOWHOPHC ENG GUIDE 200 - Extranet Systems
Reassess the diagnosis after withdrawal if headache frequency does not improve or the post-withdrawal phenotype is discordant with the presumed underlying disorder. Nature+1NatureDiagnosis and management of migraine in ten stepsNeurologyMedication overuse headache
| Clinical branch | Key discriminator | Next action |
|---|---|---|
| Simple analgesic, NSAID, triptan, or combination-analgesic overuse | Qualifying medication-day threshold without opioid dependence concerns Neurology+1NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems | Explain expected transient worsening and plan abrupt withdrawal. Nature+1NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems |
| Opioid overuse | Current opioid exposure, possible dependence, or concern for opioid-induced hyperalgesia cellcellPACAP-PAC1 receptor inhibition is effective in opioid ... | Plan gradual taper rather than routine abrupt withdrawal; involve appropriate addiction or pain-management support when needed. Nature+1NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems |
| Persistent chronic migraine after overuse is addressed | Headache remains frequent after medication withdrawal and reassessment NatureNatureDiagnosis and management of migraine in ten steps | Initiate or optimize migraine prevention with an evidence-based chronic migraine option. NatureNatureDiagnosis and management of migraine in ten steps |
| Atypical or changing headache syndrome | Current symptoms differ materially from the prior primary-headache phenotype | Evaluate for another secondary headache disorder before attributing the presentation to medication overuse. |
Detoxification
Use an explicit withdrawal plan rather than a vague reduction target
Education and a defined stop date improve implementation.
Explain that medication withdrawal is the necessary core treatment and that headache usually worsens before recovery. For overused analgesics and triptans, use abrupt discontinuation rather than gradual dose reduction. This can usually be managed in primary care when addictive drugs are not involved; opioid exposure is the major exception and should be tapered. Nature+1NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems
Set the withdrawal plan in writing: identify every acute agent to stop, establish the cessation date, review anticipated headache worsening and associated symptoms, and specify how the patient will contact the practice if withdrawal becomes unmanageable. Detoxification commonly produces predictable withdrawal symptoms, and successful detoxification is associated with improved headache outcomes and fewer monthly headache days by 8 weeks. ScienceDirectScienceDirectMedication-overuse headache: Bridging therapies for detoxification
Avoid allowing a bridge plan to become replacement overuse. Bridging therapies have been used to reduce withdrawal-headache intensity and associated symptoms, but novel acute agents including ditans and gepants require further study in this setting. If prednisone is selected for withdrawal symptoms, one cited primary-care guide lists prednisone 60 mg as possibly effective; the same guide lists amitriptyline up to 50 mg as possibly effective for withdrawal symptoms. ScienceDirect+1ScienceDirectMedication-overuse headache: Bridging therapies for detoxificationWHOPHC ENG GUIDE 200 - Extranet Systems
For analgesic or triptan overuse: stop the overused agent abruptly and prepare the patient for short-term worsening. Nature+1NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems
For opioid overuse: taper rather than abruptly discontinue; assess for opioid-related hyperalgesia and withdrawal risk. cell+2cellPACAP-PAC1 receptor inhibition is effective in opioid ...NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems
Schedule active follow-up rather than waiting for the next routine visit, because early withdrawal symptoms can undermine adherence. ScienceDirectScienceDirectMedication-overuse headache: Bridging therapies for detoxification
Preventive therapy during withdrawal
Preventive treatment for the antecedent migraine disorder can begin in parallel with acute-medication withdrawal or be initiated when the underlying headache disorder re-emerges; this timing remains debated. For chronic migraine once medication overuse has been addressed or excluded, evidence-based preventive options include topiramate, onabotulinumtoxinA, and CGRP monoclonal antibodies. NatureNatureDiagnosis and management of migraine in ten steps
When topiramate is chosen in medication-overuse headache, a cited primary-care guide identifies a maximum daily dose of 200 mg. Select the preventive agent according to the underlying migraine phenotype, prior response, comorbidities, adverse-effect risk, access, and patient preference rather than using detoxification as the sole treatment. WHO+1WHOPHC ENG GUIDE 200 - Extranet SystemsNatureDiagnosis and management of migraine in ten steps
Follow-up
Measure response by headache burden and medication days
Withdrawal success does not eliminate the need for migraine management.
At follow-up, review the same diary fields used at baseline: monthly headache days, monthly acute-medication days by class, attack severity, and migraine-related disability. Evaluate response shortly after initiating or changing therapy, at 2 to 3 months, then every 6 to 12 months once the regimen is stable. NatureNatureDiagnosis and management of migraine in ten steps
If outcomes remain suboptimal, first review whether medication overuse has recurred, whether the post-withdrawal phenotype still supports migraine, and whether the preventive strategy is being used and tolerated. A patient whose medication use no longer meets overuse thresholds but who continues to have frequent migraine needs escalation of migraine prevention rather than repeated detoxification alone. Nature+1NatureDiagnosis and management of migraine in ten stepsNeurologyMedication Overuse and Headache Burden
Prevent recurrence by discussing class-specific medication-day limits before prescribing or refilling acute treatment. Frequent acute-medication use is a modifiable risk factor for headache-frequency progression, and patients with migraine should be educated about medication-overuse risk before use becomes established. Nature+1NatureDiagnosis and management of migraine in ten stepsNeurologyMedication overuse headache
At 2 to 3 months: compare attack frequency, severity, disability, and acute-medication days with baseline. NatureNatureDiagnosis and management of migraine in ten steps
Every 6 to 12 months after stabilization: reassess efficacy, adverse effects, adherence, and return of overuse. NatureNatureDiagnosis and management of migraine in ten steps
At every acute-medication refill: reconcile OTC and prescription headache agents against the 10-day and 15-day monthly thresholds. Neurology+1NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems
| Metric | Interpretation | Next step |
|---|---|---|
| Acute-medication days by class | At least 10 days monthly for triptans, opioids, ergots, or combination analgesics, or at least 15 days monthly for simple analgesics, suggests recurrent overuse. Neurology+1NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems | Reinstitute a medication-withdrawal plan and reassess the preventive regimen. NatureNatureDiagnosis and management of migraine in ten steps |
| Headache frequency after withdrawal | Persistent frequent headaches may reflect inadequately treated chronic migraine or an alternative diagnosis. Nature+1NatureDiagnosis and management of migraine in ten stepsNeurologyMedication overuse headache | Reassess phenotype and optimize chronic migraine prevention. NatureNatureDiagnosis and management of migraine in ten steps |
| Attack severity and disability | Persistent burden despite reduced acute-medication use indicates incomplete control of the underlying headache disorder. NatureNatureDiagnosis and management of migraine in ten steps | Adjust preventive treatment and assess adherence and tolerability. NatureNatureDiagnosis and management of migraine in ten steps |
| Opioid use | Continued opioid exposure may sustain medication-overuse headache or opioid-induced hyperalgesia. cellcellPACAP-PAC1 receptor inhibition is effective in opioid ... | Continue an individualized tapering and multidisciplinary management plan. Nature+1NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems |
References
- Comparison of 3 Treatment Strategies for Medication ... — jamanetwork.com · jamanetwork.com
- Diagnosis and management of migraine in ten steps — www.nature.com · www.nature.com
- Migraine | Nature Reviews Disease Primers — www.nature.com · www.nature.com
- PACAP-PAC1 receptor inhibition is effective in opioid ... — www.cell.com · www.cell.com
- The Many Faces of Medication‐Overuse Headache in Clinical ... — headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
- Treatment of medication overuse headache – guideline ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- American Headache Society 66th Annual Scientific Meeting ... — headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
- overuse headache — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- European Academy of Neurology guideline on the ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Evidence Regarding Medication Overuse Headache in ... — headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
- American Headache Society 67th Annual Scientific Meeting ... — headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
- Medication Overuse - an overview — www.sciencedirect.com · www.sciencedirect.com
- Medication-overuse headache: Bridging therapies for detoxification — www.sciencedirect.com · www.sciencedirect.com
- Cluster Headache - an overview — www.sciencedirect.com · www.sciencedirect.com
- Drug Detoxification - an overview — www.sciencedirect.com · www.sciencedirect.com
- SPINEPASS Randomized Clinical Trial Protocol | Physical ... — academic.oup.com · academic.oup.com
- Primary Care Management of Headache - Oxford Academic — academic.oup.com · academic.oup.com
- Pilot Study of Amitriptyline in the Prophylactic Treatment of ... — academic.oup.com · academic.oup.com
- Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache — www.neurology.org · www.neurology.org
- Medication Overuse and Headache Burden — www.neurology.org · www.neurology.org
- Medication overuse headache — www.neurology.org · www.neurology.org
- PHC ENG GUIDE 200 - Extranet Systems — extranet.who.int · extranet.who.int
- Why Should We Prescribe Medications to Treat Alcohol ... — www.aasld.org · www.aasld.org
- Electronic Signature Page — cdn.clinicaltrials.gov · cdn.clinicaltrials.gov